Adequate omega-3 PUFA status in pregnant women protects against preterm birth (birth before 37 weeks gestation) and early preterm birth (birth before 34 weeks gestation), especially in those with low dietary DHA intake
Where researchers do add compounds, they are usually pursuing a different axis entirely for example a GH-axis or metabolic peptide for goals KLOW does not target
When injected, it provides a high, flat level of GH in the blood
Once reconstituted, the solution should be kept refrigerated and is typically stable for up to 2 months under proper storage conditions
The idea is to find the minimum effective dose that elicits the desired response
Physiological Expectations for Low-Dose Therapy Low-dose HGH therapy, which is 1 to 2 IU per day, is often used for anti-aging and wellness